Abstract:BackgroundInflammatory bowel disease is a chronic inflammatory disease characterized by recurrent abdominal pain and diarrhea, and gut microbiota is one of its causes. Probiotics, as one of the intervention methods of microbiota, play an important role in disease treatment. This study aims to observe the effect and immune mechanism of Clostridium butyricum MIYAIRI 588 (CBM) and it’s supernatant on colitis mice which pretreated with antibiotic cocktail (ABx).MethodsTwenty four Balb/c mice aged 6-8 weeks were randomly divided into four groups, and CBM and its supernatant was used to treat colitis mice which pretreated with ABx. The body weight, disease activity index (DAI) and colon length of mice were observed respectively. The relative expression of inflammatory cytokines in colon tissue was detected by qPCR. And the number of neutrophils, macrophages, Th1 and Th17 cells in lamina propria of mucosa was detected by flow cytometry to observe the changes of pro-inflammatory immune cells in mouse mucosa.ResultsThe DAI of mice were decreased, the shortened colon length was improved after CBM and its supernatant intervention (IDDF2021-ABS-0196 Figure1A. Clostridium butyricum and its supernatant ameliorated colitis and regulated immune cells; DAI scores of mice after C. Butyricum gavaging with antibiotic cocktail pretreatment at the end of experiment)( IDDF2021-ABS-0196 Figure1B. Clostridium butyricum and its supernatant ameliorated colitis and regulated immune cells; The macroscopic images of colon)( IDDF2021-ABS-0196 Figure 1C. Clostridium butyricum and its supernatant ameliorated colitis and regulated immune cells; The statistical analysis of colon length). The results of qPCR showed that the relative expression of pro-inflammatory cytokines TNF-α, IL-6, IL-1β, IL-17a were down-regulated after CBM and its supernatant treatment. And the relative expressions of anti-inflammatory cytokines TGF-β, IL-10, IL-4, IL-5, IL-13 were up-regulated (IDDF2021-ABS-0196 Figure1F. Clostridium butyricum and its supernatant ameliorated colitis and regulated immune cells; The amount of Th1 cells based on flow cytometry, and its statistical analysis). Flow cytometry showed that the amount of neutrophils, macrophage, Th1, Th17 cells were down-regulated which were the pro-inflammatory immune cells in intestinal mucosa lamina propria after CBM and its supernatant treatment (IDDF2021-ABS-0196 Figure1D. Clostridium butyricum and its supernatant ameliorated colitis and regulated immune cells; The amount of neutrophil based on flow cytometry, and its statistical analysis) (IDDF2021-ABS-0196 Figure1E. Clostridium butyricum and its supernatant ameliorated colitis and regulated immune cells; The amount of macrophage based on flow cytometry, and its statistical analysis) (IDDF2021-ABS-0196 Figure1F. Clostridium butyricum and its supernatant ameliorated colitis and regulated immune cells; The amount of Th1 cells based on flow cytometry, and its statistical analysis) (IDDF2021-ABS-0196 Figure1G. Clostridium butyricum and its supernatant ameliorated colitis and regulated immune cells; The amount of Th17 cells based on flow cytometry, and its statistical analysis) (IDDF2021-ABS-0196 Figure1H. Clostridium butyricum and its supernatant ameliorated colitis and regulated immune cells; The relative expression of inflammatory cytokines)ConclusionsCBM can alleviate the symptoms and colon shortening of mice with colitis after pre-treatment with ABx, improve the expression of inflammatory factors, and might play an anti-inflammatory role by down-regulating the infiltration of inflammatory immune cells in intestinal mucosa lamina propria.

Specific Immunotherapy in Combination with Clostridium Butyricum Inhibits Allergic Inflammation in the Mouse Intestine.

Combination Of Specific Allergen And Probiotics Induces Specific Regulatory B Cells And Enhances Specific Immunotherapy Effect On Allergic Rhinitis

Specific Immunotherapy Ameliorates Ulcerative Colitis.

Clostridium Butyricum in Combination with Specific Immunotherapy Converts Antigen-Specific B Cells to Regulatory B Cells in Asthmatic Patients.

Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells’ Differentiation and Function in Induction of Colitis

Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles

Probiotics Enhance the Effect of Allergy Immunotherapy on Regulating Antigen Specific B Cell Activity in Asthma Patients.

Clostridium Butyricum Combined with Bifidobacterium Infantis Probiotic Mixture Restores Fecal Microbiota and Attenuates Systemic Inflammation in Mice with Antibiotic-Associated Diarrhea.

IDDF2022-ABS-0275 Clostridium Btyricum and Metabolite Butyrate Relieve DSS-induced Colitis in Mice by Regulating IGA-coated Microbiota

Clostridium Butyricumcombined Withbifidobacterium Infantisprobiotic Mixture Restores Fecal Microbiota and Attenuates Systemic Inflammation in Mice with Antibiotic-Associated Diarrhea

Immunomodulatory effects of Clostridium butyricum on human enterocyte-like HT-29 cells

Exploration of the Effect of Probiotics Supplementation on Intestinal Microbiota of Food Allergic Mice.

Clostridium Butyricum Alleviates Intestinal Low-Grade Inflammation In Tnbs-Induced Irritable Bowel Syndrome In Mice By Regulating Functional Status Of Lamina Propria Dendritic Cells

Clostridium Butyricum Relieve the Visceral Hypersensitivity in Mice Induced by Citrobacter Rodentium Infection with Chronic Stress.

THE EFFECT AND IMMUNE CELL ANALYSIS OF CLOSTRIDIUM BUTYRICUM ON DEXTRAN SULPHATE SODIUM INDUCED COLITIS IN MICE PRETREATED WITH ANTIBIOTIC COCKTAIL

Sodium Butyrate Reduces Colitogenic Immunoglobulin A-Coated Bacteria and Modifies the Composition of Microbiota in IL-10 Deficient Mice

Probiotics Alleviate Food Protein Allergy in Mice by Activating TLR4 Signaling Pathway

Protective effect of Bifidobacterium infantis CGMCC313-2 on ovalbumin-induced airway asthma and β-lactoglobulin-induced intestinal food allergy mouse models.

Study of the alleviation effects of a combination of Lactobacillus rhamnosus and inulin on mice with colitis.

Oral Administration of a Mixture of Probiotics Protects Against Food Allergy Via Induction of CD103+ Dendritic Cells and Modulates the Intestinal Microbiota

Effect of the Butyrate on the Lymphocyte of β-Lactoglobulin-sensitized Mice in Vitro